Exemestane-RAD001-Metformin
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Exemestane|DRUG: Metformin
Sponsor: M.D. Anderson Cancer Center
Collaborators: Susan G. Komen Breast Cancer Foundation